首页> 美国卫生研究院文献>Case Reports in Transplantation >Incidental Eosinophilic Chromophobe Renal Cell Carcinoma in Renal Allograft
【2h】

Incidental Eosinophilic Chromophobe Renal Cell Carcinoma in Renal Allograft

机译:肾移植中偶发性嗜酸性嗜铬细胞肾细胞癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The incidence of renal cell carcinoma (RCC) in renal allograft in transplant recipients is 0.22–0.25%. De novo clear cell, papillary, and chromophobe RCCs and RCCs with sarcomatoid differentiation originating in renal allograft have been reported. Routine surveillance for graft tumours is not routinely practiced and these tumours are commonly asymptomatic and incidentally discovered. We describe a case of incidental, eosinophilic chromophobe RCC in a 31-year-old, long-term renal transplant male recipient, who presented with acute gastroenteritis 11 years after transplantation. The graft was nonfunctional at the time of presentation. Abdominal ultrasound and computed tomography scan demonstrated 1.8 cm well-defined, round enhancing lesion, confined to the renal allograft and suspicious for malignancy. Pathological examination of graft nephrectomy specimen showed gross, histopathological, and immunohistochemical features of eosinophilic chromophobe RCC. Fifty-five months after surgery, the patient was alive and free of malignancy. To the best of our knowledge, only five chromophobe RCCs originating in a renal allograft were previously described in English literature. We suggest that chromophobe RCC should be considered in the differential diagnosis of renal allograft mass, including eosinophilic tumours, and emphasise the importance of periodic screening of renal allograft in all renal transplant recipients.
机译:移植受体的同种异体肾细胞癌(RCC)的发生率为0.22-0.25%。已经报道了从肾脏异体移植产生的新生细胞,乳头状和生色性RCC以及具有肉瘤样分化的RCC。没有常规进行移植瘤的常规监视,这些肿瘤通常无症状,并且偶然发现。我们描述了一名31岁的长期肾移植男性接受者偶然发生的嗜酸性嗜铬细胞RCC的病例,该患者在移植后11年出现了急性胃肠炎。移植时,移植物无功能。腹部超声和计算机断层扫描显示有1.8 cm的清晰,圆形增强病灶,仅限于同种异体肾移植,可疑恶变。移植肾切除术标本的病理检查显示嗜酸性嗜铬细胞RCC的总体,组织病理学和免疫组织化学特征。手术后五个月,患者还活着,没有恶性肿瘤。据我们所知,英语文献中先前仅描述了五个源自肾脏同种异体的生色团RCC。我们建议在肾异体移植物质量(包括嗜酸性肿瘤)的鉴别诊断中应考虑使用发色团RCC,并强调在所有肾移植接受者中定期筛查肾同种异体移植的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号